Phase II trial to evaluate the ActiGait implanted drop-foot stimulator in established hemiplegia

To evaluate a selective implantable drop foot stimulator (ActiGait) in terms of effect on walking and safety. A phase II trial in which a consecutive sample of participants acted as their own controls. People who had suffered a stroke at least 6 months prior to recruitment and had a drop-foot that a...

Ausführliche Beschreibung